Organic Herb Inc Shines at CPHI China 2025

Recently, the 23rd China International Pharmaceutical Ingredients Exhibition (CPHI China 2025) were grandly held at the Shanghai New International Expo Center (Pudong). As a leading high-biotechnology manufacturer specializing in botanical extracts, Organic Herb Inc made a prominent appearance at Booth E4C62 with its core product portfolio and innovative solutions. Leveraging its stringent quality management system, advanced R&D capabilities and global market experience, the company attracted widespread attention from professional buyers, R&D institutions and industry partners at home and abroad, becoming a notable highlight in the natural extracts exhibition area.

Regarded as the "vane" and "innovation hub" of the global pharmaceutical industry, CPHI & PMEC China 2025 covered a total exhibition area of over 230,000 square meters, gathering more than 3,500 participating enterprises including over 250 international leading brands. The exhibition comprehensively displayed the entire pharmaceutical industry chain, with exhibits covering pharmaceutical raw materials, natural extracts, biotechnology, pharmaceutical excipients, contract manufacturing, pharmaceutical machinery, packaging materials and other key sectors. Particularly, the natural extracts exhibition area achieved breakthrough scale, with over 450 domestic and foreign enterprises focusing on innovative technologies and application fields of natural raw materials, providing an important platform for industry players to conduct in-depth exchanges and resource docking.

At this exhibition, Organic Herb Inc comprehensively presented its diversified product matrix, focusing on star products such as Ginseng Root Extract (80% Ginsenosides), Grape Seed Extract (95% OPC), Green Tea Extract (60% EGCG), and Resveratrol (99%), as well as characteristic products including Luo Han Guo Extract and Soy Bean Extract. Backed by its annual production capacity of 300,000kg of herbal extracts and advanced in-house laboratories, all products are manufactured in strict compliance with international quality standards such as GMP, GAP and ISO9001. The company's professional R&D and QC center in Beijing further ensures product safety and effectiveness, enabling its products to be widely applied in pharmaceutical formulations, dietary supplements, functional foods and cosmetics, and exported to more than 30 countries worldwide.

Centering on the industry trends highlighted at the exhibition, the Organic Herb Inc team provided in-depth interpretations to visiting guests on the application value of its products in pharmaceutical R&D, functional nutrition and other scenarios. Through professional technical presentations and product sample displays, the team effectively demonstrated the company's advantages in natural extract purification technology and customized solution services. The company's philosophy of "approaching health care and lifestyle naturally" and its commitment to integrating environmental factors into the entire industrial chain have resonated deeply with many participants, laying a solid foundation for in-depth cooperation.

A relevant person in charge of Organic Herb Inc stated that the company has long been committed to the R&D, production and export of botanical extracts, and has established in-depth cooperation with world-renowned universities and research institutions in safety and efficacy evaluation up to clinical phase II. Participating in CPHI & PMEC China 2025 is an important measure to deepen its layout in the domestic market and strengthen international exchanges. During the exhibition, the company has reached preliminary cooperation intentions with many domestic and foreign pharmaceutical and health care enterprises, and will further promote follow-up technical communication and order negotiation to achieve win-win development.

Against the backdrop of the accelerating integration of the global pharmaceutical and health care industry, the demand for high-quality natural extracts is continuously rising. Organic Herb Inc emphasized that it will continue to take technological innovation as the core driving force, give full play to its advantages in R&D and production, continuously enrich its product system and optimize service capabilities, so as to provide more reliable botanical extract raw materials and solutions for the global pharmaceutical and health care industry and contribute to the high-quality development of the industry.